Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

BACKGROUND: The main reason for treatment failure after curative surgical resection of gastric cancer is intra-abdominal spread, with 40–50% peritoneal seeding as primary localization of recurrence. Peritoneal relapse is seen in 60–70% of tumors of diffuse type, compared to only 20–30% of intestinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Götze, Thorsten O., Piso, Pompiliu, Lorenzen, Sylvie, Bankstahl, Ulli S., Pauligk, Claudia, Elshafei, Moustafa, Amato, Giuseppe, Reim, Daniel, Bechstein, Wolf O., Königsrainer, Alfred, Mönig, Stefan P., Rau, Beate, Schwarzbach, Matthias, Al-Batran, Salah-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555172/
https://www.ncbi.nlm.nih.gov/pubmed/34715810
http://dx.doi.org/10.1186/s12885-021-08872-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555172/
https://www.ncbi.nlm.nih.gov/pubmed/34715810
http://dx.doi.org/10.1186/s12885-021-08872-8

Ejemplares similares